Il Prof. Pengo ci racconta del neonato Registro START Antifosfolipidi, tra le cose che sappiamo e non sappiamo e come si spera che il Registro possa chiarirle.
Guarda l’intervista:
Condividi su:
CLOT+ RSS Feed- Oral anticoagulants and cognitive impairment in patients with atrial fibrillation: A systematic review with meta-analysis and trial sequential analysis.Thromb Res. 2024 May 1;238:132-140. doi: 10.1016/j.thromres.2024.04.032.
- Obese patients with atrial fibrillation are more efficiently protected from thrombosis under warfarin or xabans compared to non-obese patients; a systematic review and Meta-analysis of six randomized controlled trials.Thromb Res. 2024 Apr 24;238:88-96. doi: 10.1016/j.thromres.2024.04.022.
- Extending venous thromboembolism secondary prevention with apixaban in cancer patients. The EVE trial.J Thromb Haemost. 2024 Mar 25:S1538-7836(24)00169-7. doi: 10.1016/j.jtha.2024.03.011.